Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw

Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1Sm9YKA
via IFTTT

Read More

Health ministry proposes curbs on prescription drug ads by retailers, wholesalers and distributors

The union health ministry has proposed extending advertising restrictions on prescription drugs to retailers and distributors. This change will bar them from advertising certain medicines without prior government approval. The amendment affects drugs covered under Schedules H, H1, and X, which require medical oversight. The existing regulations already apply to pharmaceutical manufacturers. The recommendation for this amendment comes from the Drugs Technical Advisory Board.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FKdI3EX
via IFTTT

Read More

Experiments on animals set to become easier

The Centre plans to significantly change the regulations governing animal experimentation. The proposed rules aim to allow institutional ethics panels to approve most experiments. Currently, only small animal experiments can be approved at the institutional level while larger ones require central oversight.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AKjUpnS
via IFTTT

Read More

Hair fall decoded: Causes, triggers, and warning signs

For many, hair shedding can raise concerns, with various elements at play like stress, hormonal imbalances, and nutrition. Recognizing the difference between shedding and breakage is essential, as each has distinct roots and remedies. Noting specific loss patterns can guide you towards effective treatments. Additionally, seeking expert guidance can shed light on potential health issues impacting your hair's condition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L1l56pJ
via IFTTT

Read More

National Medical Commission bans doctors & hospitals from using AI-generated patient testimonials, fake cure claims in medical ads

The National Medical Commission has implemented new ethical advertising guidelines affecting doctors and hospitals. These guidelines prohibit the use of artificial intelligence for generating promotional content or testimonials. Measures have also been taken to restrict paid patient solicitation and misleading claims in advertisements. Strict penalties have been established for non-compliance, including warnings and license suspensions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GCsa0t7
via IFTTT

Read More

Govt set to cap trade margins on more cancer drugs before SC hearing

The Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda will make the announcement just ahead of a Supreme Court hearing on October 12. This decision comes after concerns regarding the price gap between retailer prices and MRP of some cancer medications. Trade margins were capped previously, leading to significant price reductions on several anti-cancer drugs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WawMSEi
via IFTTT

Read More

Supreme Court seeks committee to curb pharma firms’ unethical marketing practices

The Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns over unethical practices influencing doctors’ prescribing decisions and patient health outcomes. Petitioners are advocating for stronger legal frameworks beyond the current voluntary code. They emphasize the need for a statutory code supported by penalties to protect the right to health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OuafslW
via IFTTT

Read More